Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order valued at $200,665.31 for nuclear medicine radiopharmaceuticals on July 1, 2024, with a completion date of September 30, 2024. This firm fixed-price contract, issued without a set-aside designation, is funded by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs and will be performed in Dublin, Ohio. The awardee specializes in supplying critical radiopharmaceutical products and medical isotopes—such as technetium-99m, iodine-123, iodine-131, and specialized radiopharmaceutical therapies—to federal healthcare facilities for nuclear medicine, oncology, and diagnostic imaging applications.
This delivery order is issued under one of Cardinal Health 414, LLC's existing Indefinite Delivery Vehicle contracts with the Veterans Integrated Service Network. The company has established itself as a key supplier of time-sensitive medical isotopes and radiopharmaceuticals across multiple VA networks and federal healthcare agencies, with historical contract values ranging from thousands to over $2 million. The unrestricted, full and open competition nature of Cardinal Health's federal contracts, combined with its specialized expertise in manufacturing and distributing critical medical radiopharmaceuticals, positions it as a vital supplier supporting the VA's nuclear medicine and diagnostic imaging capabilities across its healthcare system.
Generated 12/18/25, 10:08 AM